Atossa Therapeutics, Inc. (NASDAQ:ATOS – Get Free Report) Director Jonathan Finn bought 25,000 shares of the stock in a transaction that occurred on Wednesday, April 10th. The shares were purchased at an average cost of $1.77 per share, with a total value of $44,250.00. Following the purchase, the director now directly owns 25,000 shares of […]
/PRNewswire/ BizClik, the UK s fastest-growing publishing company, has published the latest editions of Technology Magazine and Data Centre Magazine. These.
Atos is aiming to convert about half of its $5 billion debt into equity as part of the plan disclosed during a confidential meeting on Monday, Bloomberg said.
Atos has not made immediately clear who would inject cash in the company and how remaining debt terms would be renegotiated, the Bloomberg report added.